Cargando…

Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver

This study is to investigate the relationship between berberine (BBR) and mitochondrial complex I in lipid metabolism. BBR reversed high-fat diet-induced obesity, hepatic steatosis, hyperlipidemia and insulin resistance in mice. Fatty acid consumption, β-oxidation and lipogenesis were attenuated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Muyu, Alimujiang, Miriayi, Hu, Lili, Liu, Fang, Bao, Yuqian, Yin, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120465/ https://www.ncbi.nlm.nih.gov/pubmed/33994854 http://dx.doi.org/10.7150/ijbs.54604

Ejemplares similares

Bidirectional regulation of adenosine 5′‐monophosphate–activated protein kinase activity by berberine and metformin in response to changes in ambient glucose concentration
por: Xiao, Yuanyuan, et al.
Publicado: (2018)

Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation
por: Hou, Wo‐Lin, et al.
Publicado: (2017)

Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition
por: Alimujiang, Miriayi, et al.
Publicado: (2020)

The mechanism of berberine alleviating metabolic disorder based on gut microbiome
por: Wang, Han, et al.
Publicado: (2022)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Bola3 Regulates Beige Adipocyte Thermogenesis via Maintaining Mitochondrial Homeostasis and Lipolysis
por: Bai, Ningning, et al.
Publicado: (2021)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Berberine Alleviates Amyloid β-Induced Mitochondrial Dysfunction and Synaptic Loss
por: Zhao, Chunhui, et al.
Publicado: (2019)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation
por: Zhang, Jin-dong, et al.
Publicado: (2021)

Development of a Mitochondrial Targeting Lipid Nanoparticle Encapsulating Berberine
por: Hori, Ikuma, et al.
Publicado: (2023)

PARP12 is required for mitochondrial function maintenance in thermogenic adipocytes
por: Hu, Fan, et al.
Publicado: (2022)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Dietary berberine alleviates high carbohydrate diet-induced intestinal damages and improves lipid metabolism in largemouth bass (Micropterus salmoides)
por: Gong, Yulong, et al.
Publicado: (2022)

Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota
por: Wu, Chenyang, et al.
Publicado: (2022)

Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
por: Zhang, Qian, et al.
Publicado: (2011)

Enhancement of liver mitochondrial complex I and energy metabolism induced by enteritis: The key role of gut microbiota derived endotoxins
por: Fu, Lele, et al.
Publicado: (2022)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Survivin is essential for thermogenic program and metabolic homeostasis in mice
por: Alimujiang, Miriayi, et al.
Publicado: (2022)

Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Chen, Qingling, et al.
Publicado: (2023)

The Qingchangligan Formula Alleviates Acute Liver Failure by Regulating Galactose Metabolism and Gut Microbiota
por: Yin, Ruiying, et al.
Publicado: (2022)

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
por: Chang, Xinxia, et al.
Publicado: (2016)

Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy
por: Zhu, Xiaofei, et al.
Publicado: (2018)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
por: Cheng, Hao, et al.
Publicado: (2022)

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
por: Cai, Yajie, et al.
Publicado: (2023)

Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome
por: Cao, Changfu, et al.
Publicado: (2019)

Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
por: Guo, Hui-Hui, et al.
Publicado: (2019)

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine
por: Wang, Yan, et al.
Publicado: (2017)

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
por: Zhang, Mingliang, et al.
Publicado: (2021)

Transforming berberine into its intestine-absorbable form by the gut microbiota
por: Feng, Ru, et al.
Publicado: (2015)

Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis
por: Wang, Yanwen, et al.
Publicado: (2018)

FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism
por: Zhao, Fanrong, et al.
Publicado: (2022)

Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota
por: Li, Jinjin, et al.
Publicado: (2022)

Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
por: Xue, Mei, et al.
Publicado: (2015)

Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway: Berberine mitigates hepatic insulin resistance via SIRT1/Opa1
por: Xu, Jia, et al.
Publicado: (2022)

Modulating gut microbiota as an anti-diabetic mechanism of berberine
por: Han, Junling, et al.
Publicado: (2011)

Berberine influences multiple diseases by modifying gut microbiota
por: Yang, Fujie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_48bhg5iiftio2r8ljhlrsv4kdm